Cargando…
Outcomes of Peptide Vaccine GV1001 Treatment in a Murine Model of Acute Noise-Induced Hearing Loss
Noise-induced hearing loss (NIHL) is primarily caused by damage to cochlear hair cells, associated with synaptopathy. The novel cell-penetrating peptide GV1001, an antitumor agent, also has antioxidant and anti-inflammatory effects, and is otoprotective in a murine model of kanamycin-induced ototoxi...
Autores principales: | Lee, Sang-Yeon, Han, Jae Joon, Lee, Sang-Youp, Jung, Gaon, Min, Hyun Jin, Song, Jae-Jin, Koo, Ja-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070461/ https://www.ncbi.nlm.nih.gov/pubmed/32012778 http://dx.doi.org/10.3390/antiox9020112 |
Ejemplares similares
-
Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice
por: Kim, Shin Hye, et al.
Publicado: (2018) -
The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide
por: Kim, Hong, et al.
Publicado: (2016) -
The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma
por: Park, Joo Kyung, et al.
Publicado: (2016) -
The Anti-inflammatory Effect of GV1001 Mediated by the Downregulation of ENO1-induced Pro-inflammatory Cytokine Production
por: Choi, Jiyea, et al.
Publicado: (2015) -
A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways
por: Kim, Jae Hyeon, et al.
Publicado: (2022)